Skip to content

Dr. Lemahieu Nefrologie

Active
Private limited company (pre-2019)founded 200718 yrs activeBergenlaan 20, 3360 Bierbeek, BelgiumKBO/BCE: BE 0893.501.840

Dr. Lemahieu Nefrologie has been active since 2007 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €1.21M and a net result of €290k. Equity is growing by ~8.8% per year across the filed fiscal years. Its solvency ranks better than 95% of 16546 sector peers (fiscal year 2025). The computed 12-month bankruptcy probability is < 0.1% (very low).

Checked score

Score 2025
92 / 100
Excellent
The score weighs solvency, liquidity and profitability. Bankruptcy probability contributes 35%. Every signal that weighs is under Signals.
Axes · tick = 2024
Profitability98▲+12
Solvency100=
Growth78=
Track record100
Bankruptcy probability, 12 months
< 0.1% Very low
0%0.5%1.5%4%10%≥ 25%
Credit up to €110k at 30 days acceptable
Liquidity ample (current ratio 41.62; short-term debt: 2.3% and cash: 14.4% of total assets), and 2.3% of the assets are financed with debt.
Credit advice for your own amount and term

Signals

Six signals. The signal on the left, the evidence on the right.
lowers riskneutral
lowers risk · Lower-failure-rate sector
In this sector companies fail less often than the Belgian average.
Gazette · bankruptcies per sector, NACE 86
Relative position
BE, all sectors
reference
Sector 86
lower
← fewer bankruptcies more bankruptcies →
lowers risk · Annual accounts: healthy financial profile
The latest annual accounts show a healthy profile in solvency, result and liquidity.
NBB · annual accounts 2025
Solvency, return and age of the figures
Solvency
97.7%
Return on assets
23.4%
Age of the figures
9 mo
lowers risk · Long track record
A company with a long track record statistically fails less often than a young one.
KBO · incorporation date
Age against the risk zone
elevated failure risk from 2 to 8 years 18 years 0 20 y
neutral · Filed after the deadline
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 26-08-2026, 26 days later. For context: 47% of the Belgian market files late and the whole 1-to-90-day band measures 2.0% abnormal legal state against a 1.66% average. We show this as a fact and do not score it.
NBB · 10 filings
Deviation from the deadline
2025
26 d late
2024
28 d late
2023
44 d late
2022
17 d early
2021
37 d early
2020
34 d late
2019
70 d late
← before the deadline after the deadline →
neutral · The next deadline is still running
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today.
Companies Code · seven months
Position in the running window
23-09-2026 today31-12-2026 close31-07-2027 deadline
neutral · No strike-offs in the KBO publications
We found no ex-officio strike-off or cessation. Our series starts in 2021 and has gaps, so this is not a confirmation that there is nothing.
KBO publications · our coverage

Financials · fiscal year 2025, micro schema

Equity
€1.21M▼ 40.3%
2024 · €2.03M
2018: €1.04M 2019: €1.26M 2020: €1.47M 2021: €1.32M 2022: €1.51M 2023: €1.75M 2024: €2.03M
2018 → 2025
Total assets
€1.24M▼ 39.1%
2024 · €2.03M
2018: €1.05M 2019: €1.30M 2020: €1.54M 2021: €1.57M 2022: €1.53M 2023: €1.83M 2024: €2.03M
2018 → 2025
Net result
€290k▲ 6.0%
2024 · €273k
2018: €167k 2019: €219k 2020: €211k 2021: €82k 2022: €197k 2023: €240k 2024: €273k
2018 → 2025
Working capital
€1.16M▼ 40.9%
2024 · €1.96M
2018: €1.01M 2019: €1.23M 2020: €1.45M 2021: €1.32M 2022: €1.51M 2023: €1.68M 2024: €1.96M
2018 → 2025
Multi-year overview
Every figure with its change against the year before
▲ rise ▼ fall
Line20212022202320242025Trend
Equity€1.32M-€1.51M▲ 15.0%€1.75M▲ 15.9%€2.03M▲ 15.6%€1.21M▼ 40.3%
Operating result€106k-€275k▲ 159%€354k▲ 28.8%€365k▲ 3.0%€404k▲ 10.7%
Net result€82k-€197k▲ 141%€240k▲ 22.1%€273k▲ 13.7%€290k▲ 6.0%
Turnover and EBIT margin not published: the micro schema does not require them.
Result per fiscal year
Operating resultNet result
€0€200k€400kOperating result 2021: €106k€106kNet result 2021: €82k€82kOperating result 2022: €275k€275kNet result 2022: €197k€197kOperating result 2023: €354k€354kNet result 2023: €240k€240kOperating result 2024: €365k€365kNet result 2024: €273k€273kOperating result 2025: €404k€404kNet result 2025: €290k€290k20212022202320242025
The operating result has risen four years in a row; 2025 is 11% above 2024 and is the highest result in the available series.
Balance-sheet composition
2025 in colour, 2024 as the grey bar beneath
Assets €1.24M
Fixed assets €50k▼ 21.4%
Current assets €1.19M▼ 39.6%
Equity and liabilities €1.24M
Equity €1.21M▼ 40.3%
Debt €29k▲ 392%
The debt ratio rises from 0.3% to 2.3%. Equity is lower and debt is higher.
Key figures and ratios
2025 value · change against 2024
EBITDA
€421k
2024 · €380k
Cash flow
€306k
2024 · €288k
Solvency
97.7%
2024 · 99.7%
Current ratio
41.62
Quick ratio
41.62
Debt / equity
0.02
2024 · 0.00
ROE
23.9%
2024 · 13.5%
ROA
23.4%
2024 · 13.4%
Interest coverage
368.93
2024 · 6047.33
Debt
€29k
2024 · €6k
Debt ≤ 1 year
€29k
2024 · €6k
Income taxes
€126k
2024 · €120k
Green means a favourable move, even when the figure itself falls: as with debt or debt / equity.
Filed annual accounts
As filed with the NBB · 2025 against 2024
Balance sheet Code20242025
Assets
Total assets20/58€2.03M€1.24M
Fixed assets21/28€64k€50k
Tangible fixed assets22/27€64k€50k
Plant, machinery and equipment23€2k€4k
Furniture and vehicles24€55k€41k
Other tangible fixed assets26€7k€6k
Current assets29/58€1.97M€1.19M
Amounts receivable within one year40/41€8k€783
Trade receivables40-€783
Other amounts receivable41€8k-
Current investments50/53€901k€1.01M
Cash at bank and in hand54/58€1.05M€178k
Deferred charges and accrued income490/1€4k€4k
Equity and liabilities
Total equity and liabilities10/49€2.03M€1.24M
Equity10/15€2.03M€1.21M
Contributions10/11€12k€12k=
Reserves13€2.01M€1.19M
Non-distributable reserves130/1€2k€2k=
Reserves not available under the articles1311€2k€2k=
Distributable reserves133€2.01M€1.19M
Profit (loss) carried forward14€4k€4k=
Amounts payable17/49€6k€29k
Amounts payable within one year42/48€6k€29k
Trade debts44€811€45
Suppliers440/4€811€45
Taxes, remuneration and social security45€5k€23k
Taxes450/3€5k€23k
Other amounts payable47/48-€6k
Income statement Code20242025
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€15k€17k
Other operating charges640/8€2k€3k
Gross operating margin9900€382k€424k
Operating profit (loss)9901€365k€404k
Financial income75/76B€28k€13k
Recurring financial income75€28k€13k
Financial charges65/66B€63€1k
Recurring financial charges65€63€1k
Profit (loss) for the period before taxes9903€393k€416k
Income taxes67/77€120k€126k
Profit (loss) for the period9904€273k€290k
Profit (loss) for the period to be appropriated9905€273k€290k
Appropriation of the result
Profit (loss) to be appropriated9906€277k€293k
Profit (loss) brought forward from the previous period14P€4k€4k=
Transfer from equity791/2-€1.11M
Transfer to equity691/2€273k€290k
To other reserves6921€273k€290k
Profit to be distributed694/7-€1.11M
Return on contributions (dividend)694-€1.11M

The notes to these accounts (5 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.

Download as CSV

Timeline · acts, filings and financial milestones

Next filing, fiscal year 2026, expected by 31-07-2027
2026
26-08
NBB filing Annual accounts filed
fiscal year 2025 · micro schema · 26 days late
2025
31-12
Financial Highest result since 2018net €290k ▲6%
Operating result €404k, net result €290k, both a record.
28-08
NBB filing Annual accounts filed
fiscal year 2024 · micro schema · 28 days late
2024
31-12
Financial Liquidity times 15current ratio 338.88
Current ratio from 22.62 to 338.88; short-term debt falls from €78k to €6k.
31-12
Financial Equity above €2MEq €2.03M ▲15.6%
7 profitable years in a row build equity to €2.03M.
13-09
NBB filing Annual accounts filed
fiscal year 2023 · micro schema · 44 days late
2023
14-07
NBB filing Annual accounts filed
fiscal year 2022 · micro schema
2022
31-12
Financial Liquidity times 12current ratio 76.46
Current ratio from 6.18 to 76.46; short-term debt falls from €254k to €20k.
24-06
NBB filing Annual accounts filed
fiscal year 2021 · micro schema
2021
31-12
Financial Weakest financial yearnet €82k ▼61.4%
Net result drops to €82k, the lowest in the series; recovery starts the following year.
03-09
NBB filing Annual accounts filed
fiscal year 2020 · micro schema · 34 days late
2020
09-10
NBB filing Annual accounts filed
fiscal year 2019 · micro schema · 70 days late
2019
26-08
NBB filing Annual accounts filed
fiscal year 2018 · micro schema · 26 days late
2018
01-08
NBB filing Annual accounts filed
fiscal year 2017 · micro schema · 1 day late
2017
11-07
NBB filing Annual accounts filed
fiscal year 2016 · micro schema
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.

Directors · office · real estate

Directors
We have established no sitting directors for this company. We derive directors from published Gazette acts; while there are none, or none read, nothing appears here. That does not mean the company has none: the CBE keeps its own list of function holders, which we do not read.
Location & real-estate footprint
Registered office, Bierbeek
Cannot be placed on the map

This address could not be matched to a point in the Belgian address register (BOSA BEST). The address below comes straight from the Crossroads Bank.

Bergenlaan 203360 Bierbeek
Ground area
2,098 m²
Building footprint
186 m²
Volume, LiDAR
1,233 m³
Parcel 24053B0126/00F002, Flanders · tallest building 10.1 m, ±2 floors. Linked by address, not a title deed.
1 parcel
Flanders 1 (100%)
Parcel (capakey) Region Area Buildings Height / fl.
24053B0126/00F002 Flanders 2,098 m² 1 · 186 m² 10.1 m · 2 fl.
Linked by address, not proof of ownership
Methodology
via registered seat: 1
1 of 1 parcel with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.

Recognitions · licences · registrations

Legal Entity Identifier

8755007EPXUEYHLFV927
no longer live in the LEI register

Similar companies · same sector, comparable size

Of 16,628 companies in sector 86220 we hold annual accounts for 7,974. 5,504 are within a factor 10 of this equity.See the whole sector

Company data · Crossroads Bank

Identification
Legal formPrivate limited company (pre-2019)
Founded09-11-2007
Fiscal year end31-12
Activities, NACEBEL
86220Specialist medical practice
86210General medical practice
Sources
Crossroads Bank for EnterprisesNational Bank · 18 filingsAddress and cadastre registers

Data from official sources, last processed on 21-09-2026. Scores and ratios are computed by Checked and are not a credit decision.